Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04KMP
|
|||
| Drug Name |
SUVN-G3031
|
|||
| Synonyms |
LNXDUSQEXVQFGP-UHFFFAOYSA-N; UNII-65V47O9NOP; 65V47O9NOP; SCHEMBL12484542; N-[4-(1-Cyclobutyl piperidin-4-yloxy)phenyl]-2-(morpholin-4-yl)acetamide; 1394808-82-2
Click to Show/Hide
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7; ICD-9: 295] | Phase 3 | [1], [2] | |
| Company |
Suven Life Sciences Hyderabad, India
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C21H31N3O3
|
|||
| Canonical SMILES |
C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)NC(=O)CN4CCOCC4
|
|||
| InChI |
1S/C21H31N3O3/c25-21(16-23-12-14-26-15-13-23)22-17-4-6-19(7-5-17)27-20-8-10-24(11-9-20)18-2-1-3-18/h4-7,18,20H,1-3,8-16H2,(H,22,25)
|
|||
| InChIKey |
LNXDUSQEXVQFGP-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 1394808-82-2
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Histamine H3 receptor (H3R) | Target Info | Antagonist | [1], [2] |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Reactome | Histamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Monoamine Transport | |||
| GPCRs, Class A Rhodopsin-like | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.